MedPath

PALT02

Phase 4
Conditions
Dyslidemia
Registration Number
JPRN-jRCT2031200177
Lead Sponsor
Ishibashi Shun
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

1) Dyslidemia : Fasting Serum TG>=150mg/dL
2) Renal dysfunction (A:eGFR<30mL/min/1.73m^2, B:Hemodialysis, C:30<=eGFR<60mL/min/1.73m^2)

Exclusion Criteria

1) Patients with severe liver damage, cirrhosis or biliary atresia patient
2) Patients with gallstones
3) Pregnant women or women who may be pregnant
4) Patients who have had a kidney transplant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath